Danaher's takeover interest of Catalent may be on the back burner: report
Danaher Life Sciences’ interest in contract manufacturer Catalent appears to have fizzled for the moment, according to Bloomberg News.
The life sciences conglomerate has stopped its pursuit of Catalent and is no long considering a takeover, Bloomberg reported Monday afternoon, citing people familiar with the matter. It’s possible that Danaher could try and revive a deal conversation later, the publication said.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.